Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Moore

Showing results (231-240 of 269) with videos related to

Pageof 27
Sort By:
The Journal of Experimental Medicine|October 1, 1990
Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus bindingD Healey, L Dianda, J P Moore, et al.
Journal of Virology|January 1, 1995
A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade BJ P Moore, A Trkola, B Korber, et al.
The American Journal of Gastroenterology|May 1, 1993
Results of a multicenter trial using a mechanical lithotripter for the treatment of large bile duct stonesM J Shaw, R D Mackie, J P Moore, et al.
Journal of Virology|January 7, 1998
Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokinesA Trkola, W A Paxton, S P Monard, et al.
The Journal of Experimental Medicine|July 22, 1998
HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapyL Morris, J M Binley, B A Clas, et al.
Journal of Virology|January 1, 1991
Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvantJ C Griffiths, E L Berrie, L N Holdsworth, et al.
The Journal of Experimental Medicine|October 23, 1997
Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine bindingL Wu, G LaRosa, N Kassam, et al.
Plos One|December 28, 2017
Beyond greenness: Detecting temporal changes in photosynthetic capacity with hyperspectral reflectance dataMallory L Barnes, David D Breshears, Darin J Law, et al.
Virology|August 1, 1992
Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virusS P Layne, M J Merges, M Dembo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1995
Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedureH J Ditzel, J M Binley, J P Moore, et al.
Pageof 27

Showing results (231-240 of 269) with videos related to

Sort By:
Pageof 27
The Journal of Experimental Medicine|October 1, 1990
Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus bindingD Healey, L Dianda, J P Moore, et al.
Journal of Virology|January 1, 1995
A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade BJ P Moore, A Trkola, B Korber, et al.
The American Journal of Gastroenterology|May 1, 1993
Results of a multicenter trial using a mechanical lithotripter for the treatment of large bile duct stonesM J Shaw, R D Mackie, J P Moore, et al.
Journal of Virology|January 7, 1998
Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokinesA Trkola, W A Paxton, S P Monard, et al.
The Journal of Experimental Medicine|July 22, 1998
HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapyL Morris, J M Binley, B A Clas, et al.
Journal of Virology|January 1, 1991
Induction of high-titer neutralizing antibodies, using hybrid human immunodeficiency virus V3-Ty viruslike particles in a clinically relevant adjuvantJ C Griffiths, E L Berrie, L N Holdsworth, et al.
The Journal of Experimental Medicine|October 23, 1997
Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine bindingL Wu, G LaRosa, N Kassam, et al.
Plos One|December 28, 2017
Beyond greenness: Detecting temporal changes in photosynthetic capacity with hyperspectral reflectance dataMallory L Barnes, David D Breshears, Darin J Law, et al.
Virology|August 1, 1992
Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virusS P Layne, M J Merges, M Dembo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1995
Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedureH J Ditzel, J M Binley, J P Moore, et al.
Pageof 27